Literature DB >> 14749506

Insulin and leptin as adiposity signals.

Stephen C Benoit1, Deborah J Clegg, Randy J Seeley, Stephen C Woods.   

Abstract

There is now considerable consensus that the adipocyte hormone leptin and the pancreatic hormone insulin are important regulators of food intake and energy balance. Leptin and insulin fulfill many of the requirements to be putative adiposity signals to the brain. Plasma leptin and insulin levels are positively correlated with body weight and with adipose mass in particular. Furthermore, both leptin and insulin enter the brain from the plasma. The brain expresses both insulin and leptin receptors in areas important in the control of food intake and energy balance. Consistent with their roles as adiposity signals, exogenous leptin and insulin both reduce food intake when administered locally into the brain in a number of species under different experimental paradigms. Additionally, central administration of insulin antibodies increases food intake and body weight. Recent studies have demonstrated that both insulin and leptin have additive effects when administered simultaneously. Finally, we recently have demonstrated that leptin and insulin share downstream neuropeptide signaling pathways. Hence, insulin and leptin provide important negative feedback signals to the central nervous system, proportional to peripheral energy stores and coupled with catabolic circuits.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14749506     DOI: 10.1210/rp.59.1.267

Source DB:  PubMed          Journal:  Recent Prog Horm Res        ISSN: 0079-9963


  75 in total

1.  Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin.

Authors:  Kamal Rahmouni; Donald A Morgan; Gina M Morgan; Xuebo Liu; Curt D Sigmund; Allyn L Mark; William G Haynes
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

Review 2.  The neuroendocrine basis of lactation-induced suppression of GnRH: role of kisspeptin and leptin.

Authors:  M Susan Smith; Cadence True; K L Grove
Journal:  Brain Res       Date:  2010-08-19       Impact factor: 3.252

3.  Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight.

Authors:  Michael Rosenbaum; Rochelle Goldsmith; Daniel Bloomfield; Anthony Magnano; Louis Weimer; Steven Heymsfield; Dympna Gallagher; Laurel Mayer; Ellen Murphy; Rudolph L Leibel
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

Review 4.  A potential role for the hippocampus in energy intake and body weight regulation.

Authors:  Terry L Davidson; Scott E Kanoski; Lindsey A Schier; Deborah J Clegg; Stephen C Benoit
Journal:  Curr Opin Pharmacol       Date:  2007-11-26       Impact factor: 5.547

Review 5.  Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa.

Authors:  A Torsello; F Brambilla; L Tamiazzo; I Bulgarelli; D Rapetti; E Bresciani; V Locatelli
Journal:  J Endocrinol Invest       Date:  2007-12       Impact factor: 4.256

Review 6.  Central control of body weight and appetite.

Authors:  Stephen C Woods; David A D'Alessio
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

Review 7.  Modulation of appetite by gonadal steroid hormones.

Authors:  Lori Asarian; Nori Geary
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

Review 8.  Inflammation, insulin resistance, and obesity.

Authors:  Patrizia Ferroni; Stefani Basili; Angela Falco; Giovanni Davì
Journal:  Curr Atheroscler Rep       Date:  2004-11       Impact factor: 5.113

Review 9.  Emerging role of adipose tissue hypoxia in obesity and insulin resistance.

Authors:  J Ye
Journal:  Int J Obes (Lond)       Date:  2008-12-09       Impact factor: 5.095

10.  Adult type 3 adenylyl cyclase-deficient mice are obese.

Authors:  Zhenshan Wang; Vicky Li; Guy C K Chan; Trongha Phan; Aaron S Nudelman; Zhengui Xia; Daniel R Storm
Journal:  PLoS One       Date:  2009-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.